Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-03654746 in Adult ADHD
NCT00531752Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF-03654746 in attention deficit hyperactivity disorder (ADHD), sponsored by Pfizer. Started Dec 2007; status: completed.
02
Drugs
PF-03654746
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00531752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531752.